Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients-Reference-Cited by-同舟云学术

Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients

Published:2015-11 Issue:11 Volume:21 Page:1926-1931
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Caimi Paolo F.^ORCID,William Basem M.,Silva Rondon Carlos H.,Fu Pingfu,Cooper Brenda W.,Campagnaro Erica L.,Gerson Stanton L.,Reese-Koc Jane,Fox Robert,Creger Richard J.,de Lima Marcos,Lazarus Hillard M.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference28 articles.

1. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial;Schmitz;Lancet,2002

2. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

3. Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol—a groupe d'Etude des lymphomes de l'Adulte study;Haioun;J Clin Oncol,2000

4. A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma;Sabloff;Biol Blood Marrow Transplant,2007

5. Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab;Smith;Bone Marrow Transplant,2011

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carmustine in the Therapy of B-Cell Lymphomas;Clinical oncohematology;2021

2. RETRACTED ARTICLE: High-dose therapy and autologous stem cell transplantation for relapsed or high-risk diffuse large B-cell lymphoma: a nationwide survey;International Journal of Hematology;2019-11-16

3. Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma;BLOOD RESEARCH;2019-06-30

4. Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma;Leukemia & Lymphoma;2017-09-21

5. Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning;Leukemia & Lymphoma;2016-05-31